Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Pacira BioSciences Inc shares valued at $211,488 were sold by WILLIAMS KRISTEN on Jun 13 ’24. At $28.38 per share, WILLIAMS KRISTEN sold 7,452 shares. The insider’s holdings dropped to 102,912 shares worth approximately $2.9 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, GAUGLER DARYL sold 1,000 shares, netting a total of over 28,380 in proceeds. Following the sale of shares at $28.38 each, the insider now holds 116,040 shares.
Before that, HASTINGS PAUL J had sold 880 shares from its account. In a trade valued at $24,974, the Director traded Pacira BioSciences Inc shares for $28.38 each. Upon closing the transaction, the insider’s holdings decreased to 880 shares, worth approximately $0.36 million.
Analysts at Raymond James started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid December. As of August 03, 2023, TD Cowen has increased its “Market perform” rating to a “an Outperform” for PCRX.
Analyzing PCRX Stock Performance
During the last five days, there has been a drop of approximately -2.69%. Over the course of the year, Pacira BioSciences Inc shares have dropped approximately -16.45%. Shares of the company reached a 52-week high of $35.95 on 01/08/24 and a 52-week low of $25.33 on 04/26/24. A 50-day SMA is recorded $28.46, while a 200-day SMA reached $29.91. Nevertheless, trading volume fell to 0.99 million shares from 0.8 million shares the previous day.
Support And Resistance Levels for Pacira BioSciences Inc (PCRX)
According to the 24-hour chart, there is a support level at 27.53, which, if violated, would cause prices to drop to 26.87. In the upper region, resistance lies at 28.53. The next price resistance is at 28.87. RSI (Relative Strength Index) is 43.93 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.30, which suggests the price will decrease in the coming days. Percent R is at 77.01%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
